Evidence Hub

Procaine Injections in Myofascial Tension Points in the Treatment of Anxiety Disorders: A Case Series

David Vinyes

International Journal of Clinical Case Reports and Reviews, 2025

2 citations

Abstract

This case series explored the potential therapeutic effects of 0.5% procaine injections in myofascial points for patients with severe anxiety. Anxiety disorders involve excessive fear and tension, often affecting daily activities. These disorders are linked to neurological circuits, inflammatory responses, and the sympathetic nervous system, which contribute to pain and stress. Procaine, a local anesthetic, is thought to interrupt the cycle of neurogenic inflammation and nociceptor excitation, potentially alleviating symptoms of anxiety. Six patients, assessed using the Beck Anxiety Inventory, were treated with procaine injections. Results showed significant improvement: four patients (66.7%) reduced their anxiety from severe to mild, and two patients (33.3%) from severe to minimal. The pre-treatment average Beck Anxiety Inventory score was 39, and the post-treatment average was 10. These promising results suggest procaine as a possible treatment for anxiety disorders, warranting further investigation in larger clinical studies.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free